ASX Share rice
Wed 05 Aug 2020 - 10:46:pm (Sydney)

CTE Share Price

CRYOSITE LIMITEDCTEPharmaceuticals, Biotechnology & Life Sciences

CTE Company Information

Name:

Cryosite Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

13a Ferndell Street South Granville NSW Australia 2142

Phone:

61 2 8865 2000

Full Time Employees:

21

Exec. Chairman & Company Sec.:

Mr. Bryan Dulhunty BEc, ACA

Chief Operating Officer of Fin. & Admin.:

Mr. Mark Edmund Payton Byrne

Company Overview:

Cryosite Limited engages in the provision of supply chain logistics services; and management of pharmaceutical products used in clinical trials, and management of biological materials in Australia. It operates in two segments, Clinical Trials & Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials & Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, and biological services to the clinical trial and research industry. The Cord Blood and Tissues Storage segment offers long term storage for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. The company was founded in 1999 and is based in South Granville, Australia.

CTE Share Price Information

Shares Issued:

46.86M

Market Capitalisation:

$8.43M

Revenue (TTM):

$8.14M

Revenue Per Share (TTM):

$0.17

Earnings per Share:

$0.017

Profit Margin:

0.1035

Operating Margin (TTM):

$0.06

Return On Assets (TTM):

$0.01

Return On Equity (TTM):

$-15.15

Quarterly Revenue Growth (YOY):

0.057

Gross Profit(TTM):

$3.31M

Diluted Earnings Per Share (TTM):

$0.017

CTE CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$31.61K

Change To Liabilities:

$-1,687,097

Total Cashflow From Investing Activities:

$31.61K

Net Income:

$-565,157

Total Cash From Operating Activities:

$-647,536

Depreciation:

$481.05K

Other Cashflow From Investing Activities:

$57.76K

Change To Inventory:

$0.99K

Change To Account Receivables:

$574.70K

Capital Expenditures:

$26.16K

CTE Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-288,273

Net Income:

$-565,157

Gross Profit:

$3.31M

Operating Income:

$-18,898

Income Tax Expense:

$276.88K

Total Revenue:

$7.91M

Total Operating Expenses:

$3.33M

Cost Of Revenue:

$4.60M

CTE Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$6.98K

Total Liabilities:

$24.89M

Total Stockholder Equity:

$-1,716,070

Other Current Liabilities:

$47.46K

Total Assets:

$23.17M

Common Stock:

$5.86M

Other Current Assets:

$1.53M

Retained Earnings:

$-7,647,390

Other Liabilities:

$21.53M

Other Assets:

$15.83M

Cash:

$3.92M

Total Current Liabilities:

$3.35M

Property - Plant & Equipment:

$373.05K

Net Tangible Assets:

$-1,737,181

Total Current Assets:

$6.95M

Net Receivables:

$652.55K

Short-Term Investments:

$16.23M

Inventory:

$22.86K

Accounts Payable:

$239.69K

Non Currrent Assets (Other):

$13.23M

Short-Term Investments:

$16.23

Non Current Liabilities (Other):

$578.14K

Non Current Liabilities Total:

$21.53M

CTE Share Price History

CTE News

18 May, 2020
Cryosite Limited (ASX:CTE) shareholders will doubtless be very grateful to see the share price up 60% in the last...
18 Nov, 2019
Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...
20 Sep, 2019
Cryosite Limited (ASX:CTE) continues its loss-making streak, announcing negative earnings for its latest financial...

CTE Dividend Payments

EX-Date Dividend Amount
2012-03-15$0.0050
2012-09-28$0.0050
2013-03-17$0.0050
2013-09-23$0.0100
2014-03-16$0.0050
2014-09-08$0.0100
2015-03-12$0.0050
2015-09-08$0.0050
2016-03-10$0.0050
2016-09-07$0.0050
2017-03-13$0.0050

CTE Dividends (last 6 Years)